https://www.selleckchem.com/pr....oducts/bay-2413555.h
ctivating the AMPK/PPARα/PGC-1α/UCP2 signal pathway to improve mitochondrial structure and energy metabolism thereby alleviate vascular cognitive impairment. SMYZD may provide a potential therapeutic strategy via activating the AMPK/PPARα/PGC-1α/UCP2 signal pathway to improve mitochondrial structure and energy metabolism thereby alleviate vascular cognitive impairment.[This retracts the article DOI 10.2147/IJN.S70449.].[This corrects the article DOI 10.2147/IJN.S209646.].[This corrects the article DOI 10.2147/IJN.S134983.].[This cor
Giống
Bình luận
Đăng lại
